Senior Director, Global Access Strategy

ROLE SUMMARY

Biosimilars promise to deliver quality essential medicines with significant cost savings for health care systems and patients. Pfizer currently has the industry's broadest portfolio of oncology biosimilars. The competitive environment is crowded, and excess price erosion is a risk. Global and local teams have limited resources and need agile processes to compete for business while retaining profitability. The primary responsibility of the Secondee is to support the global price and access execution for this portfolio. An important part of this assignment is to streamline key processes and optimize organizational efficiency.

ROLE RESPONSIBILITIES

• Lead the Oncology Biosimilars Access Matrix Team
• Review and approve pricing requests for the 3 mAb assets in the Oncology Biosimilars portfolio (Zirabev, Trazimera, Ruxience) with focus on Int'l. Markets and EM
• Finalize new bid price approval process using GTCS and roll-out to markets; transition mAb products from Category B to Category C
• Ensure markets have tools and training needed to execute bidding strategies effectively
• Finalize new price projection algorithms by providing review and input to cross-functional team
• Develop OP27 bid price guidance and streamline process
• Seek efficiencies by ensuring key bid related tasks sit with persons who have closest proximity to requisite data and expertise and require minimum number of approvers
• Provide payer/access insights to support ad hoc analyses relating to market events; scan horizon for upcoming events to facilitate planning
• Deliver clear recommendations relating to payer/buyer strategy, pricing and reimbursement, evidence generation, data collection and value propositions.
• Work efficiently and collaboratively in a highly matrixed environment, orchestrating multiple activities to accomplish a goal

Achieving the above will require leadership and/or participation in cross functional teams. The position requires close collaboration with colleagues including HVE, commercial, PGS, Pricing Dynamics, Finance, Medical, ICO, and the International Commercial Execution team. The Secondee will report to the Team Lead for Oncology Supportive Care and Biosimilars.

BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of external stakeholders to achieve meaningful outcomes and create business impact.

• Masters (MSc, MPH) or Doctoral degree (PhD, Dr PH, ScD) in health services research, public health, epidemiology, or health economics
• Minimum 10 years' experience with MBA/MS or 7 years' experience with PharmD/PhD, in a combination of Market Access, policy or Health Economics
• Able to independently engage all levels of stakeholders through a strong customer orientation, strategic thinking, leading change, and building collaborative partnerships in a matrix environment
• Knowledge and experience in oncology therapeutic areas is desirable
• Demonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly
• Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities in a compliant manner
• Excellent oral and written English communication skills are required

Other Job Details:

• Last Date to Apply for Job: January 4th, 2026.
• Ability to travel internationally (25%)
• NOT Eligible for Relocation Package
• Secondment 6 months
• Candidates located in US East Coast or Western Europe are preferred
• If you are currently in a driving position with a fleet vehicle and this secondment does not require driving as an essential function of the position for 12 months or longer, you will be required to turn in your fleet vehicle for the duration of the non-driving secondment. Please refer to the Fleet Policy and Procedures document for more information.

Relocation assistance may be available based on business needs and/or eligibility.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations.  These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure.  Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act.  Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government.  If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status.  Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA.  Pfizer is an E-Verify employer.  This position requires permanent work authorization in the United States.

Pfizer endeavors to make  accessible to all users. If you would like to contact us regarding the accessibility of our website or need assistance completing the application process and/or interviewing, please email  This is to be used solely for accommodation requests with respect to the accessibility of our website, online application process and/or interviewing. Requests for any other reason will not be returned.